TARS

TARS Change in Working Capital

$38.45MTTM · USD

Period ending:

TARS FY Change in Working CapitalUSD
TARS FY Change in Working Capital2018-12-31: $126.00K2019-12-31: $485.00K2020-12-31: $1.46M2021-12-31: $1.37M2022-12-31: -$951.00K2023-12-31: $306.00K2024-12-31: $3.84M2025-12-31: $14.64M$14.64M-$951.00K
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TARS change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Tarsus Pharmaceuticals Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
14,638,000
3,844,000
306,000
-951,000
1,372,000
1,458,000
485,000
126,000

Compare change in working capital

All TARS financial metrics · TARS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.